Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 9, 2006, Pages 3494-3498

  Ergun Longmire, Berrin ^a   Mertens, Ann C ^b   Mitby, Pauline ^b   Qin, Jing ^c   Heller, Glenn ^c   Shi, Weiji ^c   Yasui, Yutaka ^d   Robison, Leslie L ^e   Sklar, Charles A ^c  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; RECOMBINANT GROWTH HORMONE;

ADOLESCENT; ADULT; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; NEWBORN; PRIORITY JOURNAL;

EID: 33748756346     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0656     Document Type: Article

References (21)

1. Clayton PE, Shalet SM 1991 Dose dependency of time of onset of radiation-induced growth hormone deficiency. J Pediatr 118:226-282
2. Sklar CA, Constine LS 1995 Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys 31:1113-1121
3. Gleeson HK, Stoeter R, Ogilvy-Stuart AL, Gattamaneni HR, Brennan BM, Shalet SM 2003 Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement. J Clin Endocrinol Metab 88:3682-3689
4. Brownstein CM, Mertens AC, Mitby PA, Stovall M, Qin J, Heller G, Robison LL, Sklar CA 2004 Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study. J Clin Endocrinol Metab 89:4422-4427
5. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE 2000 The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215-244
6. Sklar CA 2004 Growth hormone treatment: cancer risk. Horm Res 62 (Suppl 3):30-34
7. Moshang Jr T, Rundle AC, Graves DA, Nickas J, Johanson A, Meadows A 1996 Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience. J Pediatr 128:S4-S7
8. Swerdlow AJ, Reddingius RE, Higgins CD, Spoudeas HA, Phipps K, Qiao Z, Ryder WD, Brada M, Hayward RD, Brook CG, Hindmarsh PC, Shalet SM 2000 Growth hormone treatment of children with brain tumors and risk of tumor recurrence. J Clin Endocrinol Metab 85:4444-4449
9. Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, Yasui Y, Robison LL 2002 Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 87:3136-3141
10. Leung W, Rose SR, Zhou Y, Hancock ML, Burstein S, Schriock EA, Lustig R, Danish RK, Evans WE, Hudson MM, Pui CH 2002 Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 20:2959-2964
11. Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, Li FP, Meadows AT, Mulvihill JJ, Neglia JP, Nesbit ME, Packer RJ, Potter JD, Sklar CA, Smith MA, Stovall M, Strong LC, Yasui Y, Zeltzer LK 2002 Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol 38:229-239
12. Andersen P, Borgan O, Gill R, Keiding N 1991 Statistical methods based on counting processes, 1st ed. Berlin: Springer
13. Mann I, Yates PC, Ainslie JP 1953 Unusual case of double primary orbital tumour. Br J Ophthalmol 37:758-762
14. Neglia JP, Meadows AT, Robison LL, Kim TH, Newton WA, Ruymann FB, Sather HN, Hammond GD 1991 Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 325:1330-1336
15. Pollak L, Walach N, Gur R, Schiffer J 1998 Meningiomas after radiotherapy for tinea capitis-still no history. Tumori 84:65-68
16. Strojan P, Popovic M, Jereb B 2000 Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature. Int J Radiat Oncol Biol Phys 48:65-73
17. Al-Mefty O, Topsakal C, Pravdenkova S, Sawyer JR, Harrison MJ 2004 Radiation-induced meningiomas: clinical, pathological, cytokinetic, and cytogenetic characteristics. J Neurosurg 100:1002-1013
18. Jostel A, Mukherjee A, Hulse PA, Shalet SM 2005 Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivors. Clin Endocrinol (Oxf) 62:698-705
19. Kamiguchi H, Shiobara R, Toya S 1996 Accidentally detected brain tumors: clinical analysis of a series of 110 patients. Clin Neurol Neurosurg 98:171-175
20. Kuratsu J, Kochi M, Ushio Y 2000 Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 92:766-770
21. Pottern LM, Kaplan MM, Larsen PR, Silva JE, Koenig RJ, Lubin JH, Stovall M, Boice Jr JD 1990 Thyroid nodularity after childhood irradiation for lymphoid hyperplasia: a comparison of questionnaire and clinical findings. J Clin Epidemiol 43:449-460.